96 related articles for article (PubMed ID: 31141522)
1. Engineering of plasmin-resistant forms of streptokinase and their production in Bacillus subtilis: streptokinase with longer functional half-life.
Wu XC; Ye R; Duan Y; Wong SL
Appl Environ Microbiol; 1998 Mar; 64(3):824-9. PubMed ID: 9501422
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of PEGylated ciliary neurotrophic factor superagonist variant in diet-induced obesity mice.
Battista MR; Grigoletto A; Tedeschini T; Cellucci A; Colaceci F; Laufer R; Pasut G; Di Marco A
PLoS One; 2022; 17(3):e0265749. PubMed ID: 35316287
[TBL] [Abstract][Full Text] [Related]
3. Development of Site-Specific PEGylated Granulocyte Colony Stimulating Factor With Prolonged Biological Activity.
Kumari M; Sahni G; Datta S
Front Bioeng Biotechnol; 2020; 8():572077. PubMed ID: 33330413
[TBL] [Abstract][Full Text] [Related]
4. Direct comparison of two extended half-life PEGylated recombinant FVIII products: a randomized, crossover pharmacokinetic study in patients with severe hemophilia A.
Solms A; Shah A; Berntorp E; Tiede A; Iorio A; Linardi C; Ahsman M; Mancuso ME; Zhivkov T; Lissitchkov T
Ann Hematol; 2020 Nov; 99(11):2689-2698. PubMed ID: 32974838
[TBL] [Abstract][Full Text] [Related]
5. Recombinant expression, purification and PEGylation of Paneth cell peptide (cryptdin-2) with value added attributes against Staphylococcus aureus.
Kaur N; Dilawari R; Kaur A; Sahni G; Rishi P
Sci Rep; 2020 Jul; 10(1):12164. PubMed ID: 32699335
[TBL] [Abstract][Full Text] [Related]
6. Serpin regulation of fibrinolytic system: implications for therapeutic applications in cardiovascular diseases.
Al-Horani RA
Cardiovasc Hematol Agents Med Chem; 2014; 12(2):91-125. PubMed ID: 25374013
[TBL] [Abstract][Full Text] [Related]
7. Molecular basis of fibrinolysis, as relevant for thrombolytic therapy.
Collen D; Lijnen HR
Thromb Haemost; 1995 Jul; 74(1):167-71. PubMed ID: 8578451
[TBL] [Abstract][Full Text] [Related]
8. Site-specific PEGylation of micro-plasmin for improved thrombolytic therapy through engineering enhanced resistance against serpin mediated inhibition.
Kaur N; Sinha PK; Sahni G
PLoS One; 2019; 14(5):e0217234. PubMed ID: 31141522
[TBL] [Abstract][Full Text] [Related]
9. Plasmin-mediated fibrinolysis by variant recombinant tissue plasminogen activators.
Urano S; Metzger AR; Castellino FJ
Proc Natl Acad Sci U S A; 1989 Apr; 86(8):2568-71. PubMed ID: 2523073
[TBL] [Abstract][Full Text] [Related]
10. Thrombolytic efficacy of recombinant human microplasmin in a canine model of copper coil-induced coronary artery thrombosis.
Dommke C; Turschner O; Stassen JM; Van de Werf F; Lijnen HR; Verhamme P
J Thromb Thrombolysis; 2010 Jul; 30(1):46-54. PubMed ID: 19834783
[TBL] [Abstract][Full Text] [Related]
11. Analysis of plasminogen activation by the plasmin-staphylokinase complex in plasma of alpha2-antiplasmin-deficient mice.
Okada K; Ueshima S; Tanaka M; Fukao H; Matsuo O
Blood Coagul Fibrinolysis; 2000 Oct; 11(7):645-55. PubMed ID: 11085285
[TBL] [Abstract][Full Text] [Related]
12. Secondary-site binding of Glu-plasmin, Lys-plasmin and miniplasmin to fibrin.
Suenson E; Thorsen S
Biochem J; 1981 Sep; 197(3):619-28. PubMed ID: 6459779
[TBL] [Abstract][Full Text] [Related]
13. Fibrinolysis with des-kringle derivatives of plasmin and its modulation by plasma protease inhibitors.
Komorowicz E; Kolev K; Machovich R
Biochemistry; 1998 Jun; 37(25):9112-8. PubMed ID: 9636057
[TBL] [Abstract][Full Text] [Related]
14. Investigation of the Use of a Bio-Derived Solvent for Non-Solvent-Induced Phase Separation (NIPS) Fabrication of Polysulfone Membranes.
Dong X; Al-Jumaily A; Escobar IC
Membranes (Basel); 2018 May; 8(2):. PubMed ID: 29735925
[TBL] [Abstract][Full Text] [Related]
15. Intravitreal gas for symptomatic vitreomacular adhesion: a synthesis of the literature.
Neffendorf JE; Simpson ARH; Steel DHW; Desai R; McHugh DA; Pringle E; Jackson TL
Acta Ophthalmol; 2018 Nov; 96(7):685-691. PubMed ID: 28857483
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
